FiberCel Tuberculosis Lawsuits Under Investigation Following Recall

Last Updated on May 17, 2023

Investigation Complete

Comments |

Case Update

May 16, 2023 – Investigation Closed

At A Glance

This Alert Affects:
Patients who underwent surgery using a now-recalled FiberCel Fiber Viable Bone Matrix product and developed tuberculosis (TB) following their procedure.
What’s Going On?
Attorneys working with believe these patients could file lawsuits for the cost of revision surgery and damages resulting from their TB diagnosis. They are offering to speak, free of charge, to those interested in learning more about their legal rights.
How Could a Lawsuit Help?
A lawsuit could provide patients with compensation for medical bills, lost wages, pain and suffering, and more.